HIGHLIGHTS
- who: (adriamycin et al. from the Clinical Research Center, College of Medicine, Inha University have published the paper: Combination treatment for osteosarcoma with baculoviral vector mediated gene therapy (p53) and chemotherapy (adriamycin), in the Journal: (JOURNAL)
- what: The authors demonstrate that Saos-2 tumor cells can be killed by p53-induced apoptosis, mediated with a recombinant baculovirus carrying p53 gene under the control of CMV promoter.
- how: The results showed that BV-p53 induced cell death in a dosedependent manner for example 26 ± 2% 60 ± 1.5% and 91 ± 5% with an m . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.